| PDF (767kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-268414
- DOI to cite this document:
- 10.5283/epub.26841
Alternative links to fulltext:Pubmed
Abstract
Fleroxacin is a new fluoroquinolone with a broad antibacterial spectrum and a serum half-life of about 8-12 h. Eighty percent of 400 isolates from complicated or hospital-acquired urinary tract infections were inhibited by a concentration of 1 mg/l and 95% by 4 mg/l. As with other quinolones, fleroxacin is less active in acid urine (pH 5.4) than in Mueller-Hinton broth (pH 7.4). In 12 healthy ...

Owner only: item control page